ABOUT THE SERVICE
Neridronate is a differentiated, third-generation bisphosphonate being developed as a potential disease-modifying therapy for patients with warm CRPS-1. It is the focus of our Phase 3 pivotal trial, CRPS-RISE.
Information is owner-confirmed
Last updated 5 months ago
Price range